SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Irel13.375 Regulatory News (BOI)

Share Price Information for Bank Irel13.375 (BOI)

Share Price is delayed by 15 minutes
Get Live Data
188.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
BOI Live PriceLast checked at - London Stock Exchange

Intraday Bank Irel13.375 Share Chart

New Contract

11 May 2006 07:01

Biotrace International PLC11 May 2006 For Immediate Release 11 May 2006 BIOTRACE INTERNATIONAL PLC ("Biotrace", "the Company" or "the Group") Company Awarded NATO Defence Contract Biotrace International Plc, a leading manufacturer of industrial microbiologyproducts, announces that it has been awarded a contract by the North AtlanticTreaty Organisation (NATO) Maintenance and Supply Agency ("NAMSA") to supplythree Field laboratories. Following a competitive tendering process, NAMSA awarded a contract to BiotraceMicroSafe for the supply of three Nuclear, Biological and Chemical ("NBC") fieldlaboratories and associated equipment. These will be deployed by the ItalianArmy in any contaminated areas for operations in Italy and missions abroad. The total contract value for the three NBC laboratories is €1.74 million (£1.2million) with delivery in the last quarter of 2006. Ian Johnson, Chief Executive Officer of Biotrace, said: "To date our Defence business has represented a modest percentage of Grouprevenues and has largely been driven by sales of products to a single customer,the UK Ministry of Defence. This has resulted in sales being better in someyears than others depending on system usage and world events. The acquisition of MicroSafe in Italy just over six months ago has broadeningthe customer base and expanded Defence revenues substantially. Thissignificant contract win from a major new customer demonstrates our enhancedcapability to deliver complete solutions for military and homeland defence andis a great endorsement of our technology and expertise in addressing thisspecialist market. Whilst the Defence business remains difficult to predict, greater opportunitiesnow exist for growth with this contract adding significantly to revenues in2006." -ENDS- For further information, please contact:Biotrace International Plc Ian Johnson, Chief Executive Officer Tel : +44 (0) 1656 641 400Peter Morgan, Finance Director Buchanan CommunicationsTim Anderson / James Strong Tel: +44 (0)20 7466 5000 Notes to editors: Biotrace International Plc is a leading manufacturer and supplier of industrialmicrobiology products. The Company is organised into three business segments:Food & Environmental, Pharmaceutical, Personal Care & Cosmetics and Defence.The Group's proprietary technologies are used by most of the world's leadingfood and beverage manufacturers who rely on Biotrace products as an essentialpart of their quality control procedures. Other industrial customers includepharmaceutical and personal care product/cosmetics manufacturers together withenvironmental/industrial process water clients. The Defence segment providessystems and consumables for the rapid detection of biological weapons formilitary and homeland security organisations. Formed in 1988 and floated on the London Stock Exchange in 1993, Biotrace hadtotal revenues of over £29 million in 2005. The Company is headquartered inBridgend, UK with manufacturing and sales operations worldwide. Visit Biotraceat www.biotrace.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jan 20067:01 amRNSTrading Update
16th Jan 20067:00 amRNSDistribution agreement
14th Dec 20053:03 pmRNSDirectorate Change
24th Nov 20057:03 amRNSInterim Results
13th Oct 20055:20 pmRNSShareholder Interest
27th Sep 20054:03 pmRNSHolding(s) in Company
21st Sep 20055:23 pmRNSNotification of Shares
21st Sep 200510:15 amRNSB&W Branch Network Sale
15th Sep 20055:19 pmRNSHolding(s) in Company
31st Aug 200510:10 amRNSBlocklisting Interim Review
19th Jul 20057:00 amRNSHalf Year Trading Update
24th May 20057:01 amRNSBristol & West Branch Network
24th May 20057:01 amRNSBristol & West Branch Network
24th May 20057:01 amRNSB&W savings and branches
24th May 20057:00 amRNSNew Broker and Adviser
12th May 200512:09 pmRNSAGM Statement
12th May 20057:02 amRNSFinal Results
28th Apr 20054:22 pmRNSHolding(s) in Company
19th Apr 20054:05 pmRNSAnnual Report and Accounts
12th Apr 20059:48 amRNSHolding(s) in Company
22nd Mar 20053:27 pmRNSDirector Shareholding
15th Mar 200510:56 amRNSHolding(s) in Company
8th Mar 20057:00 amRNSFinal Results
22nd Feb 20057:01 amRNSNotice of Results
7th Feb 20052:47 pmRNSHolding(s) in Company
1st Feb 20052:21 pmRNSBlocklisting Interim Review
7th Jan 20058:00 amRNSDirector Shareholding
6th Jan 200512:49 pmRNSHolding(s) in Company
6th Jan 20057:00 amRNSTrading Update
5th Jan 200510:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.